Novartis (NVS)

Add to Watchlists Create an Alert
73.82 -0.80  -1.07%   NYSE May 23, 8:00PM BATS Real time Currency in USD

Novartis Enterprise Value:

196.42B for May 23, 2013
View Full Chart

Novartis Enterprise Value Chart

    Novartis Historical Enterprise Value Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 65   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    May 23, 2013 196.42B
    May 22, 2013 198.39B
    May 21, 2013 198.41B
    May 20, 2013 197.25B
    May 17, 2013 197.23B
    May 16, 2013 199.34B
    May 15, 2013 200.55B
    May 14, 2013 198.31B
    May 13, 2013 198.46B
    May 10, 2013 199.17B
    May 9, 2013 197.40B
    May 8, 2013 199.25B
    May 7, 2013 195.24B
    May 6, 2013 194.28B
    May 3, 2013 195.61B
    May 2, 2013 195.63B
    May 1, 2013 196.03B
    April 30, 2013 196.27B
    April 29, 2013 196.22B
    April 26, 2013 194.48B
    April 25, 2013 194.63B
    April 24, 2013 193.13B
    April 23, 2013 194.97B
    April 22, 2013 193.45B
    April 19, 2013 193.03B
       
    April 18, 2013 192.00B
    April 17, 2013 191.60B
    April 16, 2013 196.00B
    April 15, 2013 195.83B
    April 12, 2013 195.02B
    April 11, 2013 195.12B
    April 10, 2013 192.83B
    April 9, 2013 190.55B
    April 8, 2013 190.87B
    April 5, 2013 188.38B
    April 4, 2013 189.56B
    April 3, 2013 190.67B
    April 2, 2013 190.28B
    April 1, 2013 189.64B
    March 28, 2013 184.18B
    March 27, 2013 182.24B
    March 26, 2013 183.62B
    March 25, 2013 181.78B
    March 22, 2013 183.19B
    March 21, 2013 182.73B
    March 20, 2013 184.37B
    March 19, 2013 181.90B
    March 18, 2013 179.48B
    March 15, 2013 180.91B
    March 14, 2013 178.63B

    About Enterprise Value

    Click "Learn More" below to see how YCharts calculates Enterprise Value.

    Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

    EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
    Learn More

    Get data for

    NVS Enterprise Value Benchmarks

    Companies
    Sanofi 157.06B
    Pfizer 214.92B
    GlaxoSmithKline 167.12B

    NVS Enterprise Value Rankings

    Overall 99th percentile
    30 of 8009
    Sector 99th percentile
    3 of 687 in Healthcare
    Industry 94th percentile
    3 of 55 in Drug Manufacturers - Major

    NVS Enterprise Value Range, Past 5 Years

    Minimum 78.31B Mar 3 2009
    Maximum 200.55B May 15 2013
    Average 137.45B